Maria Oliva-Hemker (Johns Hopkins University School of Medicine, Baltimore, MD, US) spoke with touchIMMUNOLOGY around recommendations for initiating thiopurine and methotrexate therapy. The presentation ‘Treatment Updates: Where Do Immunomodulators Fit in Current Approaches to Therapy?’ was presented at the virtual 2021 Crohn’s & Colitis Congress.
Questions
- What recommendations do you suggest when initiating thiopurine therapy? (0:04)
- What do you recommend when initiating methotrexate therapy? (3:37)
Disclosures: Maria Oliva-Hemker has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media.
Filmed as a highlight of CCC 2021 (Virtual).
